# BIODELIVERY SCIENCES INTERNATIONAL INC

BIODELIVERY SCIENCES INTERNATIONAL INC is a company headquartered in Raleigh, NC, United States.

## Company overview

- **Legal name:** BIODELIVERY SCIENCES INTERNATIONAL INC
- **Former names in filing history:** MAS ACQUISITION XXIII CORP (2000-04-13 to 2000-04-18)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Raleigh, NC, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001103021

## About

BIODELIVERY SCIENCES INTERNATIONAL INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001103021, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-03-09, it reported annual revenue of USD 166,703,000; net income of USD 84,860,000; total assets of USD 324,596,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $166.7M (USD 166,703,000)
- **Net income:** $84.9M (USD 84,860,000)
- **Total assets:** $324.6M (USD 324,596,000)
- **Cash and equivalents:** $114.3M (USD 114,300,000)
- **Operating cash flow:** $41.0M (USD 41,037,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $156.5M (USD 156,471,000)
- **Net income:** $25.7M (USD 25,711,000)
- **Total assets:** $239.9M (USD 239,894,000)
- **Cash and equivalents:** $111.6M (USD 111,584,000)
- **Operating cash flow:** $25.0M (USD 24,981,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $111.4M (USD 111,389,000)
- **Net income:** -$15.3M (USD -15,305,000)
- **Total assets:** $182.9M (USD 182,905,000)
- **Cash and equivalents:** $63.9M (USD 63,888,000)
- **Operating cash flow:** $11.1M (USD 11,072,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $55.6M (USD 55,640,000)
- **Net income:** -$33.9M (USD -33,867,000)
- **Total assets:** $108.5M (USD 108,533,000)
- **Cash and equivalents:** $43.8M (USD 43,822,000)
- **Operating cash flow:** -$24.1M (USD -24,113,000)

## Recent SEC filings

- Form 8-K — filed 2022-03-22 — period 2022-03-22 — FORM 8-K
- Form 10-K — filed 2022-03-09 — period 2021-12-31 — 10-K
- Form SC 13D — filed 2022-02-24 — SC 13D
- Form SC 13G — filed 2022-02-24
- Form 8-K — filed 2022-02-14 — period 2022-02-13 — 8-K
- Form 8-K — filed 2022-01-20 — period 2022-01-20 — 8-K
- Form 8-K — filed 2021-12-21 — period 2021-12-20 — 8-K
- Form 10-Q — filed 2021-11-03 — period 2021-09-30 — 10-Q
- Form 8-K — filed 2021-11-03 — period 2021-11-03 — 8-K
- Form 8-K — filed 2021-10-21 — period 2021-10-21 — 8-K
- Form 8-K — filed 2021-09-27 — period 2021-09-27 — 8-K
- Form 8-K — filed 2021-09-21 — period 2021-09-21 — 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/biodelivery-sciences-international-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology